Pfizer Inc.

NYSE-PFE

OverviewFinancialsInvestor RelationsResearchEstimatesNewsOwnershipIndustryDividendsModelingFilings

Assets	Jun '25	Dec '24	Jun '24	Dec '23	Jul '23	Dec '22
Cash and Cash Equivalents	1,638	1,043	1,052	2,853	2,632	416
Cash and Cash Equivalents
Short-Term Investments	11,611	19,434	6,048	9,837	42,153	22,316
Short-Term Investments
Restricted Short-Term Investments
Total Cash and Cash Equivalents	13,249	20,477	7,100	12,690	44,785	22,732
Accounts Receivable	12,078	11,463	11,393	11,566	10,231	10,952
Trade Accounts Receivable, Net of Allowance for Doubtful Accounts
Total Trade Receivables	12,078	11,463	11,393	11,566	10,231	10,952
Inventories	11,669	10,851	11,447	10,189	10,310	8,981
Inventories
Other Current Assets	6,706	7,567	7,884	8,889	8,022	8,594
Current Deferred Tax Assets and Other Current Tax Assets
Current Tax Assets
Other Current Assets
Assets Held for Sale
Current Assets of Discontinued Operations and Other Assets Held for Sale
Total Current Assets	43,703	50,358	37,825	43,333	73,347	51,259
Total Current Assets
Net Property, Plant & Equipment	18,776	18,393	18,957	18,940	17,488	16,274
Property, Plant and Equipment, Net of Accumulated Depreciation
Net Intangible Assets	52,702	55,411	61,240	64,900	41,406	43,370
Identifiable Intangible Assets, Net
Goodwill	68,997	68,527	68,445	67,783	51,572	51,375
Goodwill
Long-Term Investments	2,120	2,228	11,148	15,368	15,066	15,069
Equity-Method Investments
Long-Term Investments
Other Long-Term Assets	19,798	18,479	18,577	16,177	21,289	19,856
Noncurrent Deferred Tax Assets and Other Noncurrent Tax Assets
Other Noncurrent Assets
Noncurrent Assets of Discontinued Operations
Total Assets	206,095	213,396	216,193	226,501	220,168	197,205
Total Assets

Liabilities	Jun '25	Dec '24	Jun '24	Dec '23	Jul '23	Dec '22
Accounts Payable	5,166	5,633	5,106	6,710	6,081	6,809
Trade Accounts Payable
Accrued Expenses	2,447	3,838	2,566	2,776	1,972	3,407
Accrued Compensation and Related Items
Short-Term Debt	4,295	6,946	11,944	10,350	3,985	2,945
Short-Term Borrowings, Including Current Portion of Long-Term Debt
Unearned Revenue	1,123	1,511	2,528	2,700	1,286	2,520
Deferred Revenues
Other Current Liabilities	24,695	25,067	21,674	25,258	21,322	26,458
Dividends Payable
Income Taxes Payable
Other Current Liabilities
Current Liabilities of Discontinued Operations
Total Current Liabilities	37,726	42,995	43,819	47,794	34,647	42,138
Total Current Liabilities
Long-Term Debt	57,502	57,405	57,506	61,538	61,356	32,884
Long-Term Debt
Other Long-Term Liabilities	21,855	24,499	26,894	27,880	24,871	26,265
Pension Benefit Obligations
Postretirement Benefit Obligations
Pension and Postretirement Benefit Obligations
Postretirement Benefit Obligations, Net
Noncurrent Deferred Tax Liabilities
Other Taxes Payable
Other Noncurrent Liabilities
Total Long-Term Liabilities	79,357	81,904	84,400	89,418	86,227	59,149
Total Liabilities	117,083	124,899	128,218	137,213	120,875	101,288
Total Liabilities

Equity	Jun '25	Dec '24	Jun '24	Dec '23	Jul '23	Dec '22
Preferred Stock	—	—	—	—	—	—
Preferred Stock, No Par Value, at Stated Value
Common Stock	481	480	480	478	478	476
Common Stock
Treasury Stock	-115,010	-114,763	-114,757	-114,487	-114,482	-113,969
Treasury Stock, Shares at Cost
Treasury Stock
Additional Paid-in Capital	94,053	93,603	93,197	92,631	92,329	91,802
Additional Paid-in Capital
Accumulated Other Comprehensive Income	-8,438	-7,842	-7,816	-7,961	-8,102	-8,304
Accumulated Other Comprehensive Loss
Retained Earnings	117,609	116,725	116,596	118,353	128,796	125,656
Retained Earnings
Total Common Shareholders' Equity	88,695	88,203	87,700	89,014	99,019	95,661
Total Pfizer Inc. Shareholders' Equity
Minority Interests and Other	317	294	275	274	274	256
Equity Attributable to Noncontrolling Interests
Total Shareholders' Equity	89,012	88,497	87,975	89,288	99,293	95,916
Total Equity
Total Liabilities and Shareholders' Equity	206,095	213,396	216,193	226,501	220,168	197,205
Total Liabilities and Equity